摘要
人类首例基因编辑婴儿事件引发了关于代理同意的新思考。在人类首次以“生育”为目的的生殖细胞系基因编辑临床研究中,受试父母未能获得真正的知情同意,也就难以代理人类后代做出是否同意的决定。为此,在未来的基因编辑技术临床研究中,要格外重视知情同意的伦理审查,开展针对性的研究。
The event of the world’s first genetically edited babies raises novel puzzle of proxy consent. In the first clinical study of gene-edited germ cell lines for the purpose of ’fertility’, the subjects’ parents were not sufficiently informed, so it is controversial whether the parents of the subjects have the right to consent on behalf of their offsprings. Therefore, we suggest that ethical review of informed consent related to clinical research on gene editing technology should be strengthened in the future and it is necessary to launch research on this issue.
作者
田文凤
张新庆
TIAN Wen-feng;ZHANG Xin-qing(School of nursing, Shandong University of Traditional Chinese Medicine;School of Humanities and Social Sciences, Peking Union Medical College)
出处
《科学与社会》
CSSCI
2019年第2期14-22,45,共10页
Science and Society
基金
国家自然科学基金项目“我国医学科研人员伦理认知和态度研究”(L1824002)
